ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
26.63
+0.60 (2.31%)
Dec 24, 2024, 1:00 PM EST - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $897.36 million as of December 24, 2024.
Market Cap
897.36M
Enterprise Value
614.71M
1-Year Change
n/a
Ranking
Category
Stock Price
$26.63
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $897.36M, an increase of 56.00%. That is a compound annual growth rate of 62.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 897.36M | 56.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 89bio | 933.60M |
| Poseida Therapeutics | 921.06M |
| Nuvation Bio | 902.00M |
| LENZ Therapeutics | 897.35M |
| Aveanna Healthcare Holdings | 884.97M |
| Phibro Animal Health | 878.52M |
| Pacira BioSciences | 876.37M |
| AMN Healthcare Services | 873.41M |